BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1387598)

  • 41. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.
    Deguchi K; Izumi K; Noguchi M; Yuwasaki E; Suzuki H; Mori Y; Deguchi A; Ohkubo I; Tsuda M; Wada H
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis.
    Homma S; Masunaga Y; Kurosu M; Inoue M; Sakurai T; Asano Y
    Perit Dial Int; 2002; 22(2):178-83. PubMed ID: 11990401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.
    van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W
    Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
    Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
    Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased tissue-type plasminogen activator antigen release is not accompanied by increased systemic fibrinolytic activity in severe neonatal respiratory distress syndrome.
    Brus F; Oetomo SB; Schieving J; Groothuis E; Okken A; van Oeveren W
    Pediatr Res; 1999 Apr; 45(4 Pt 1):588-94. PubMed ID: 10203153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
    Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Shibata A
    Am J Hematol; 1991 Apr; 36(4):255-8. PubMed ID: 1826408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
    Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.
    Di Minno MN; Iervolino S; Peluso R; Di Minno A; Ambrosino P; Scarpa R;
    J Rheumatol; 2014 Apr; 41(4):714-22. PubMed ID: 24532831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo.
    Jones CI; Payne DA; Hayes PD; Naylor AR; Bell PR; Thompson MM; Goodall AH
    J Vasc Surg; 2008 Sep; 48(3):715-22. PubMed ID: 18572351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.
    Comerota AJ; Chouhan V; Harada RN; Sun L; Hosking J; Veermansunemi R; Comerota AJ; Schlappy D; Rao AK
    Ann Surg; 1997 Sep; 226(3):306-13; discussion 313-4. PubMed ID: 9339937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolonged activation of fibrinolytic system induced by fibrin nonselective thrombolytic agent can contribute to preventing early reocclusion after coronary thrombolytic therapy.
    Goto S; Kawai Y; Handa S; Takahashi E; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Cardiology; 1993; 82(4):274-9. PubMed ID: 8402754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes.
    Agren A; Jörneskog G; Elgue G; Henriksson P; Wallen H; Wiman B
    Diabetes Care; 2014 Jul; 37(7):2007-14. PubMed ID: 24760258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of tissue plasminogen activator activity by aspirin in vivo and its relationship to levels of tissue plasminogen activator inhibitor antigen, plasminogen activator and their complexes.
    Levin RI; Harpel PC; Harpel JG; Recht PA
    Blood; 1989 Oct; 74(5):1635-43. PubMed ID: 2529003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrinolytic activity in laparoscopic cholecystectomy.
    Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S
    J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrinolytic and inflammatory processes in pleural effusions.
    Philip-Joët F; Alessi MC; Philip-Joët C; Aillaud M; Barriere JR; Arnaud A; Juhan-Vague I
    Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.